Pathological and clinical predictors for response to neoadjuvant chemotherapy in breast cancer

被引：0
|
作者：
MacGrogan, G
Pallud, C
Simonie-Lafontaine, J
Sagan, C
Verrielle, V
Antoine, M
Ettore, F
Treilleux, J
Tas, P
Bellocq, JP
Ulusakarya, A
机构：
[1] Inst Bergonie, Bordeaux, France
[2] Ctr Val Aurelle, Montpellier, France
[3] CHU Paris Tenon, Paris, France
[4] Ctr Antoine Lacassagne, F-06054 Nice, France
[5] CHU Strasbourg, F-67000 Strasbourg, France
来源：
MODERN PATHOLOGY | 2003年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
162
引用
收藏
页码：39A / 39A
页数：1
相关论文
共 50 条
  • [41] Feasibility Assessment of Pharmacogenomic Predictors Developed from Breast Cancer Cell Lines To Predict Breast Cancer Patient Pathological Response in Neoadjuvant Chemotherapy
    Shen, K.
    Rice, S.
    Gingrich, D.
    Wang, D.
    Tian, C.
    Ding, Z.
    Brower, S.
    Ervin, P.
    Huang, S.
    Gabrin, M.
    Song, N.
    [J]. CANCER RESEARCH, 2010, 70
  • [42] Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer
    Hayashi, Mitsuhiro
    Yamamoto, Yutaka
    Iwase, Hirotaka
    [J]. CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [43] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    [J]. CANCER RESEARCH, 2011, 71
  • [44] Magnetic Resonance Imaging to predict pathological response neoadjuvant chemotherapy for breast cancer
    Lamot, C.
    Van fraeyenhove, F.
    Denys, H.
    Van Herreweghe, E.
    Van den Broecke, R.
    Villeirs, G.
    Depypere, H.
    Praet, M.
    Cocquyt, V.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 60 - 61
  • [45] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [46] Factors predicting a pathological complete response following neoadjuvant chemotherapy for breast cancer
    Choi, H.
    Van Belle, V.
    Wildiers, H.
    Paridaens, R.
    Amant, F.
    Van Limbergen, E.
    Moerman, P.
    Smeets, A.
    Vergote, I.
    Neven, P.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 66 - 67
  • [47] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [48] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [49] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
    Cordoba Ortega, J. F.
    Gasol Cudos, A.
    Morales Murillo, S.
    Vilardell Villellas, F.
    Siso Raber, C.
    Canosa Morales, C.
    Salud Salvia, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
  • [50] Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
    Hamy, Anne-Sophie
    Derosa, Lisa
    Valdelievre, Constance
    Yonekura, Satoru
    Opolon, Paule
    Priour, Mael
    Guerin, Julien
    Pierga, Jean-Yves
    Asselain, Bernard
    De Croze, Diane
    Pinheiro, Alice
    Lae, Marick
    Talagrand, Laure-Sophie
    Laas, Enora
    Darrigues, Lauren
    Grandal, Beatriz
    Marangoni, Elisabetta
    Montaudon, Elodie
    Kroemer, Guido
    Zitvogel, Laurence
    Reyal, Fabien
    [J]. ONCOIMMUNOLOGY, 2020, 9 (01):
12345